PATENT CLAIM ANALYSIS

Application Number: 15953141
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "094600"]

Abstract:
The present invention relates to an artificially manipulated neovascularization-associated factor for regulating neovascularization and a use thereof. More particularly, the present invention relates to a system for artificially regulating neovascularization, which includes an artificially manipulated neovascularization-associated factor for regulating neovascularization and/or a composition for artificially manipulating the neovascularization-associated factor. In a specific aspect, a neovascularization regulatory system including a neovascularization-associated factor such as artificially manipulated VEGFA, HIF1A, ANGPT2, EPAS1, or ANGPTL4 and/or an expression product thereof is provided.

Claim (Index 3):
The composition for gene manipulation of  claim 2 , wherein the editor protein is a  Streptococcus pyogenes -derived Cas9 protein or  Campylobacter jejuni -derived Cas9 protein.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.95556
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15415431', '15935334', '15360627', '14213479', '15060448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7128803605296871
- 35 USC 102 Novelty (BERT): 0.5219612840308725
- Combined Prediction Score: 0.6937884528798056
- Mean Citation Score: 310.590658
- Max Citation Score: 324.7946
- Similarity Product: 242.56963783209324

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test